4.6 Article

The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

Ying Zhou et al.

Summary: Drug discovery relies not only on knowledge of drugs and targets, but also on understanding comparative agents and targets. This study introduces a major update to the Therapeutic Target Database, providing valuable data on poor binders, non-binders, prodrug-drug pairs, co-targets, and drug-like properties, as well as additional features for advanced search and cross-links to target structures. The database is accessible without login requirement at: https://idrblab.org/ttd/.

NUCLEIC ACIDS RESEARCH (2022)

Article

A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways

Fereshteh Nazari-Khanamiri et al.

Journal of Basic and Clinical Physiology and Pharmacology (2022)

Review Plant Sciences

The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis

Xufei Luo et al.

Summary: Chinese herbal medicine or combination therapy may be effective in controlling symptoms and reducing the rate of disease progression for COVID-19, although evidence quality is currently low.

PHYTOMEDICINE (2021)

Article Plant Sciences

Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

Nannan Shi et al.

Summary: The study found that Lopinavir-Ritonavir has some efficacy in treating COVID-19, and the Huashi Baidu Formula may enhance this effect. Additionally, a combination of the Huashi Baidu Formula and traditional Chinese medicine injection showed superiority in the treatment of COVID-19.

PHYTOMEDICINE (2021)

Article Food Science & Technology

Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms

Chenglin Mu et al.

Summary: The study analyzed the binding affinity of chemical compounds in Rhizoma Polygonati with SARS-CoV-2 proteins, suggesting the potential of these compounds to target different viral and cancer-related signaling pathways. This indicates the potential of compounds in Rhizoma Polygonati for the treatment of COVID-19.

JOURNAL OF FUNCTIONAL FOODS (2021)

Article Hematology

Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis

Matthew L. Meizlish et al.

Summary: In this study of hospitalized COVID-19 patients, intermediate-dose anticoagulation and aspirin treatment were each associated with a significantly lower cumulative incidence of in-hospital death as shown by propensity score matching and multivariable regression analysis.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Medicine, Research & Experimental

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

Keng-Chang Tsai et al.

Summary: The traditional Chinese medicine formula NRICM101 has shown promising results in treating COVID-19 patients by inhibiting the virus and reducing inflammation, potentially serving as a multi-target agent for prevention and treatment.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Biochemistry & Molecular Biology

Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6

Wen-hao Niu et al.

Summary: The study identified active chemical constituents in traditional Chinese medicine proven effective for COVID-19 treatment and found that compounds in these medicines, such as quercetin, ursolic acid, luteolin, and rutin, can down-regulate IL-6, potentially leading to anti-inflammatory effects against the virus.

BIOSCIENCE REPORTS (2021)

Article Medicine, General & Internal

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)

Chaolin Huang et al.

Summary: This study aimed to investigate the long-term health consequences of discharged COVID-19 patients and associated risk factors, particularly disease severity. Patients with more severe illness during hospitalization showed more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations, highlighting the need for targeted interventions for long-term recovery.

LANCET (2021)

Article Plant Sciences

Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study

Lihua Zhang et al.

Summary: The study showed that the use of Qingfei Paidu Tang (QPT) was associated with a significantly lower in-hospital mortality rate among patients with COVID-19, without additional risks of acute liver injury or acute kidney injury.

PHYTOMEDICINE (2021)

Article Pharmacology & Pharmacy

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics

Dan-Yang Liu et al.

Summary: A pharmacologic and transcriptomic approach was used to screen drug candidates novel for COVID-19 treatment, resulting in the identification of individual drug candidates and synergistic drug combinations. Most repurposing drugs significantly impacted B cells. The findings may accelerate the discovery of an effective therapeutic treatment plan for COVID-19 patients.

PHARMACEUTICS (2021)

Article Plant Sciences

Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China

Yu Wang et al.

Summary: The study aimed to evaluate the efficacy and safety of Chinese Medicine (CM) in COVID-19 patients compared to Western Medicine (WM) by analyzing a retrospective case series study in Wuhan Jinyintan Hospital. The results showed significant differences between CM and WM groups in terms of clinical manifestations, imaging findings, and laboratory examinations, with higher nucleic acid negative conversion rate and more absorbed lung lesions in the CM group, as well as significant decreases in high sensitivity C-reactive protein and serum ferritin levels.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

A review of pharmacological and pharmacokinetic properties of Forsythiaside A

Lihong Gong et al.

Summary: Forsythiaside A, the main active compound isolated from Forsythiae Fructus, exhibits significant bioactivities in treating various diseases such as inflammation, virus infection, neurodegeneration, and oxidative stress. Modern pharmacological studies have shown that Forsythiaside A regulates multiple signaling pathways to exert anti-inflammatory, antiviral, neuroprotective, antioxidant effects, providing promising clinical applications.

PHARMACOLOGICAL RESEARCH (2021)

Article Endocrinology & Metabolism

Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19

Nils Kappelmann et al.

Summary: Most COVID-19 survivors experience long-term neuropsychiatric symptoms like fatigue, sleeping difficulties, depression, and anxiety, potentially driven by neuroimmune cross-talk involving inflammatory cytokines like IL-6. Targeting IL-6 pathways may offer new treatment and prevention strategies for these symptoms.

PSYCHONEUROENDOCRINOLOGY (2021)

Review Infectious Diseases

Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments

Shin Jie Yong

Summary: Long COVID or post-COVID-19 syndrome is a poorly understood condition that affects survivors with symptoms like fatigue, dyspnoea, cognitive impairments, and more. The pathophysiology, risk factors, and treatments are still lacking in literature, but potential treatments may include rehabilitation training and repurposed drugs from similar conditions. Further research is needed to substantiate risk factors and treatment options.

INFECTIOUS DISEASES (2021)

Article Pharmacology & Pharmacy

Cinnamaldehyde Inhibits Inflammation of Human Synoviocyte Cells Through Regulation of Jak/Stat Pathway and Ameliorates Collagen-Induced Arthritis in Rats

Wen-Xiang Cheng et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Medicine, Research & Experimental

Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools

Qi Kong et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Medicine, General & Internal

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)

Pei-Fang Wei

CHINESE MEDICAL JOURNAL (2020)

Article Health Care Sciences & Services

Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19

Shengwei Yu et al.

ANNALS OF PALLIATIVE MEDICINE (2020)

Review Public, Environmental & Occupational Health

COVID-19 and comorbidities: Deleterious impact on infected patients

Hasan Ejaz et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Review Medicine, General & Internal

Drug treatments for covid-19: living systematic review and network meta-analysis

Reed A. C. Siemieniuk et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Mathematical & Computational Biology

Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology

Ying Huang et al.

BIODATA MINING (2020)

Review Pharmacology & Pharmacy

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease

Chih-Chao Chiang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Integrative & Complementary Medicine

Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real-World Database

Yen-Chu Lu et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)

Article Cell Biology

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway

Weiguo Wang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping

Yang Wu et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemical Research Methods

Reactome graph database: Efficient access to complex pathway data

Antonio Fabregat et al.

PLOS COMPUTATIONAL BIOLOGY (2018)

Article Biochemical Research Methods

Reactome pathway analysis: a high-performance in-memory approach

Antonio Fabregat et al.

BMC BIOINFORMATICS (2017)

Article Biochemistry & Molecular Biology

The SIDER database of drugs and side effects

Michael Kuhn et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Multidisciplinary Sciences

Network-based in silico drug efficacy screening

Emre Guney et al.

NATURE COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

Vanessa J. Craig et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)

Review Respiratory System

Coagulation and anticoagulation in idiopathic pulmonary fibrosis

Michael G. Crooks et al.

EUROPEAN RESPIRATORY REVIEW (2015)

Article Chemistry, Multidisciplinary

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

Jinlong Ru et al.

JOURNAL OF CHEMINFORMATICS (2014)

Review Integrative & Complementary Medicine

Traditional Chinese medicine network pharmacology: theory, methodology and application

Li Shao et al.

CHINESE JOURNAL OF NATURAL MEDICINES (2013)

Article Biotechnology & Applied Microbiology

A human functional protein interaction network and its application to cancer data analysis

Guanming Wu et al.

GENOME BIOLOGY (2010)

Article Integrative & Complementary Medicine

An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study

Chung-Hua Hsu et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)

Article Integrative & Complementary Medicine

The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients

Chung-Hua Hsu et al.

AMERICAN JOURNAL OF CHINESE MEDICINE (2006)